The role of vaccines in preventing and eradicating numerous infectious diseases is unparalleled; however, the past year has presented some new challenges for the industry, calling into question the scientific rigor behind these life-saving advances. This panel will highlight the importance of public support for scientific innovation, policies that can strengthen R&D and scientific discourse as well as how best to shore up confidence in science across the biopharma ecosystem. Panelists will explore vaccines as an example, the benefits versus risks, healthcare costs, and how to help rebuild trust to support global health with perspectives from industry, government, advocacy, research, and academia.